- €102.68m
- €99.57m
- €82.34m
- 45
- 16
- 65
- 33
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 57.1 | 67.6 | 75.9 | 80.8 | 82.3 |
Cost of Revenue | |||||
Gross Profit | 43.5 | 53.6 | 61.4 | 66.4 | 69.4 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 67.1 | 69.4 | 84.9 | 92.8 | 82.9 |
Operating Profit | -9.99 | -1.83 | -8.97 | -12 | -0.523 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -10.8 | -2.32 | -9.22 | -12.2 | -0.705 |
Provision for Income Taxes | |||||
Net Income After Taxes | -10.9 | -2.24 | -8.91 | -15.6 | -0.803 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -10.9 | -2.24 | -8.91 | -15.6 | -0.803 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -10.9 | -2.24 | -8.91 | -15.6 | -0.802 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.596 | -0.049 | -0.486 | -0.772 | 0.014 |
Dividends per Share |